Research Summary

My research concerns access, delivery, and organization of substance abuse treatment services. My experience in this area includes studies evaluating efforts to improve access to publicly funded drug abuse treatment, assessing federal policy to end addiction as an SSI disability category, evaluating needle exchange as an HIV prevention strategy, and investigating interventions for drug-involved offenders. In recent years, my work has focused on tobacco dependence in addictions treatment, because of the high rate of smoking in this population, because of the known health consequences, and because of the increasing evidence that quitting smoking in addictions treatment also improves drug abuse outcomes.
 

Research Funding

  • September 30, 2013 - August 31, 2017 - Marketing, FDA communication, tobacco perceptions and use in addiction treatment , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DA036066
  • September 29, 1994 - May 31, 2016 - Treatment for Complex Patients: Continuing and Extended Care , Principal Investigator . Sponsor: NIH, Sponsor Award ID: P50DA009253
  • April 20, 2006 - March 31, 2012 - Organizational Change and Nicotine Dependence Treatment , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DA020705
  • August 1, 2009 - July 31, 2011 - Impact of Core Implementation Components on Adoption , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DA025600
  • August 25, 2001 - July 31, 2006 - Integrating Multi-Assessment Protocols into Practice , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DA014470
  • January 1, 1999 - December 31, 2001 - DRUG ABUSE TREATMENT--DEMAND IMPACTS IN SAN FRANCISCO , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DA012221

Education

Washington State University, Pullman, WA, BS, 1977, Psychology
Fort Hays State University, Hays, KS, MS, 1982, Clinical Psychology
Washington State University, Pullman, WA, PhD, 1987, Clinical Psychology
University of California, San Francisco, CA, Postdoc Fellow, 1987-1988, Behavioral Medicine
University of California, San Francisco, Research Fellow, 1988-1990, AIDS Prevention Studies
University of California, Berkeley, CA, MPH, 1990, Epidemiology

Selected Publications

  1. Saura J, Feliu A, Enríquez-Mestre M, Fu M, Ballbè M, Castellano Y, Pla M, Rosa N, Radeva P, Maestre-González E, Cabezas C, Colom J, Suelves JM, Mondon S, Barrio P, Andreu M, Raich A, Bernabeu J, Vilaplana J, Roca Tutusaus X, Guydish J, Fernández E, Martínez C. Patterns of Use and Withdrawal Syndrome in Dual Cannabis and Tobacco Users (DuCATA_GAM-CAT): Protocol for a Mixed Methods Study. JMIR Res Protoc. 2024 Sep 19; 13:e58335.  View on PubMed
  2. McCuistian C, Lisha NE, Campbell B, Cheng C, Le J, Guydish J. Reducing tobacco use in substance use treatment: The California tobacco free initiative. Addict Behav. 2024 08; 155:108025.  View on PubMed
  3. Campbell BK, Le T, McCuistian C, Bonniot C, Delucchi K, Guydish J. Policy and Practice Changes Associated with a Tobacco-Free Initiative in Residential Substance Use Disorder Treatment. J Psychoactive Drugs. 2024 Feb 16; 1-10.  View on PubMed
  4. Rosa N, Feliu A, Ballbè M, Alaustre L, Vilalta E, Torres N, Nieva G, Pla M, Pinet C, Raich A, Mondon S, Barrio P, Andreu M, Suelves JM, Vilaplana J, Enríquez M, Castellano Y, Guydish J, Fernández E, Martínez C. Quitline nurses' experiences in providing telephone-based smoking cessation help to mental health patients: A mixed methods study. J Psychiatr Ment Health Nurs. 2024 Oct; 31(5):755-766.  View on PubMed
  5. Accurso EC, Cordell KD, Guydish J, Snowden LR. Exploring Demographic and Clinical Characteristics of Racially and Ethnically Diverse Youth With Eating Disorders Using California Medicaid Claims Data. J Am Acad Child Adolesc Psychiatry. 2024 Jun; 63(6):615-623.  View on PubMed
  6. Pagano A, Le T, Fong T, Reid R, Delucchi K, Guydish J. Gambling, tobacco use, and health among individuals in substance use disorder treatment. Am J Addict. 2023 11; 32(6):563-573.  View on PubMed
  7. Fu M, Castellano Y, Laroussy K, Baena A, Margalef M, Feliu A, Galimany-Masclans J, Puig-Llobet M, Moreno-Arroyo C, Sancho R, Bueno A, López A, Guydish J, Fernández E, Martínez C. Passive exposure and perceptions of smoke-free policies in hospital and university campuses among nursing students: A cross-sectional multicenter study. Tob Induc Dis. 2023; 21:93.  View on PubMed
  8. Guydish J, McCuistian C, Hosakote S, Le T, Masson CL, Campbell BK, Delucchi K. A cluster-randomized trial of a brief multi-component intervention to improve tobacco outcomes in substance use treatment. Subst Abuse Treat Prev Policy. 2023 06 16; 18(1):34.  View on PubMed
  9. Martínez C, Lisha N, McCuistian C, Straus E, Delucchi K, Guydish J. Corrigendum: Comparing client and staff reports on tobacco-related knowledge, attitudes, beliefs and services provided in substance use treatment. Tob Induc Dis. 2023; 21:59.  View on PubMed
  10. Campbell BK, Le T, Pagano A, McCuistian C, Woodward-Lopez G, Bonniot C, Guydish J. Addressing nutrition and physical activity in substance use disorder treatment: Client reports from a wellness-oriented, tobacco-free policy intervention. Drug Alcohol Depend Rep. 2023 Jun; 7:100165.  View on PubMed
  11. Martínez C, Lisha N, McCuistian C, Strauss E, Deluchi K, Guydish J. Comparing client and staff reports on tobacco-related knowledge, attitudes, beliefs and services provided in substance use treatment. Tob Induc Dis. 2023; 21:45.  View on PubMed
  12. Feliu A, Fernández E, Castellano Y, Enríquez M, Saura J, Cabezas C, Colom J, Suelves JM, Pla M, Parejo M, Mondon S, Barrio P, Andreu M, Raich A, Bernabeu J, Vilaplana J, Roca X, Bautista P, Guydish J, Martínez C, group of clinicians involved in the recruitment of the study. Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study. Addict Sci Clin Pract. 2022 11 30; 17(1):66.  View on PubMed
  13. Masson CL, Gubner NR, Benowitz N, Hosakote S, Le T, Guydish JR. Lifetime use of non-nicotine drugs in electronic cigarette devices among a sample of individuals in substance use disorder treatment. Addict Behav Rep. 2022 Dec; 16:100465.  View on PubMed
  14. Pagano A, McCuistian C, Le T, Campbell BK, Delucchi K, Woodward-Lopez G, Guydish J. Smoking Behavior and Wellness among Individuals in Substance Use Disorder Treatment. J Psychoactive Drugs. 2023 Jul-Aug; 55(3):330-341.  View on PubMed
  15. Fokuo JK, McCuistian CL, Masson CL, Gruber VA, Straus E, Wong J, Guydish JR. Pre-implementation Assessment of Tobacco Cessation Interventions in Substance Use Disorder Residential Programs in California. Subst Use Misuse. 2022; 57(9):1345-1355.  View on PubMed
  16. Martínez C, Feliu A, Torres N, Nieva G, Pinet C, Raich A, Mondon S, Barrio P, Andreu M, Hernández-Ribas R, Vicens J, Costa S, Suelves JM, Vilaplana J, Enríquez M, Alaustre L, Vilalta E, Subirà S, Bruguera E, Castellano Y, Saura J, Guydish J, Fernández E, Ballbè M. Acceptability and participation predictors for a pragmatic randomized controlled trial to test a smoking cessation intervention after discharge from mental health wards. Drug Alcohol Depend. 2022 05 01; 234:109390.  View on PubMed
  17. Campbell BK, Le T, McCuistian C, Hosakote S, Kapiteni K, Guydish J. Implementing tobacco-free policy in residential substance use disorders treatment: Practice changes among staff. Drug Alcohol Depend Rep. 2022 Mar; 2:100033.  View on PubMed
  18. Fitzpatrick CM, Anderson BT, Agin-Liebes G, Guydish J. Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms. J Psychoactive Drugs. 2022 Sep-Oct; 54(4):324-327.  View on PubMed
  19. McCuistian C, Kapiteni K, Le T, Safier J, Delucchi K, Guydish J. Reducing tobacco use in substance use treatment: An intervention to promote tobacco-free grounds. J Subst Abuse Treat. 2022 04; 135:108640.  View on PubMed
  20. McCuistian C, Le T, Delucchi K, Pagano A, Hosakote S, Guydish J. Racial/Ethnic Differences in Tobacco Use and Cessation Services among Individuals in Substance Use Treatment. J Psychoactive Drugs. 2021 Nov-Dec; 53(5):483-490.  View on PubMed

Go to UCSF Profiles, powered by CTSI